Tumor de colisión de útero. Reporte de caso y revisión de la literatura / Uterine collision tumor. Case report and review of he literature

Objetivos: Reportar el caso de una paciente con tumor de colisión del útero y realizar una revisión de la literatura respecto al diagnóstico histopatológico, tratamiento y pronóstico de esta condición. Materiales y métodos: Mujer de 76 años que consultó al centro nacional de referencia del cáncer en Bogotá (Colombia), donde se hizo el diagnóstico de tumor de colisión del útero, compuesto por un adenocarcinoma de endometrio tipo seroso y adenosarcoma de cérvix. Recibió tratamiento quirúrgico más quimioterapia y radioterapia complementaria, falleció a los 16 meses. Se realizó una búsqueda de la literatura en las bases de datos Medline vía PubMed y Embase, que incluía reportes y series de caso de mujeres con diagnóstico de tumor de colisión del útero, y se extrajo información sobre el diagnóstico, tratamiento y pronóstico. Se realizó un resumen narrativo de los hallazgos. Resultados: La búsqueda identificó 36 títulos, de los cuales se incluyeron 14 estudios que incluían 17 pacientes. El diagnóstico histopatológico más frecuente fue el adenocarcinoma endometrioide de endometrio y sarcoma endometrial de alto y bajo grado (47 %). El tratamiento básico fue quirúrgico. Cerca del 50 % recibió tratamiento adyuvante con quimioterapia y radioterapia (15 %). La sobrevida a un año fue del 75 %. Conclusiones: En la literatura no se identificaron casos de tumores de colisión de útero con la histopatología y en la ubicación del caso presentado. La mortalidad a dos años es cercana al 28 % si se toma en cuenta el caso reportado. Se necesitan más estudios que describan la inmunohistoquímica, el tratamiento y el pronóstico de esta condición.

Objectives: To report the case of a patient with a uterine collision tumor and to conduct a review of the literature. Material and methods: A 76-year-old patient who presented to the national cancer referral center in Bogota (Colombia), where she was diagnosed with a uterine collision tumor consisting of a serous-type endometrial adenocarcinoma and a cervical adenosarcoma. The patient underwent surgical treatment followed by chemotherapy and supplemental radiotherapy, and died 16 months later. A search was conducted in the Medline via PubMed and Embase databases, including reports and case series of women with a diagnosis of uterine collision tumor, with retrieval of information regarding diagnosis, treatment and prognosis. A narrative summary of the findings was made. Results: The search identified 36 titles, of which 14 studies with 17 patients were included. The most frequent histopathological diagnosis was endometrial adenocarcinoma and high and low grade endometrial sarcoma (47 %). Primary treatment was surgery and adjuvant treatment with chemotherapy and radiotherapy (15 %) was performed in close to 50 % of cases. One-year survival was 75 %. Conclusions: No cases of uterine collision tumors with the histopathology or in the location of the reported case were found in the literature. If this reported case is taken into account, 2-year mortality is 28 %. Further studies to describe the immunohistochemistry, treatment and prognosis of this condition are needed.

Repercussões da braquiterapia na qualidade de vida e funcionalidade no tratamento do câncer de colo uterino / Effects of brachytherapy on quality of life and functionality in the treatment of cervix cancer / Efectos de la braquiterapia sobre la calidad de vida y la funcionalidad en el tratamiento del cáncer de cuello uterino

RESUMO Objetivo: avaliar a repercussão da braquiterapia sobre funcionalidade e qualidade de vida de mulheres com câncer de colo uterino. Método: estudo transversal descritivo, desenvolvido entre dezembro de 2019 e fevereiro de 2020, com 33 mulheres com neoplasia uterina em tratamento braquiterápico, acompanhadas no Centro Oncológico do Nordeste - Brasil. Foi aplicado o instrumento Funtional Assessment of Cancer Theraphy - Cervix Cancer. Foram comparadas as médias das subescalas e analisada a correlação entre elas por meio da aplicação dos testes ANOVA e t de Student. Resultados: foram evidenciadas demandas voltadas para a autoimagem, sexualidade e queixas urinárias. A média de preocupações adicionais foi menor na faixa de 50-59 quando comparada com a média da faixa de 31-49 (p=0,004) e com a de 60-75 (p=0,002). Conclusão: abordar assuntos voltados para sexualidade e queixas urinárias contribuem para a identificação precoce dos sintomas ocasionados pela braquiterapia, assim como implementação de medidas, proporcionando qualidade de vida à paciente.

ABSTRACT Objective: to assess the effect of brachytherapy on functionality and quality of life of women with cervix cancer. Method: a descriptive and cross-sectional study carried out between December 2019 and February 2020 with 33 women with uterine neoplasia undergoing brachytherapy, followed up at Centro Oncológico do Nordeste - Brazil. The Funtional Assessment of Cancer Therapy - Cervix Cancer instrument was applied. The means of the subscales were compared and their mutual correlation was analyzed by applying the ANOVA and Student's t tests. Results: requirements focused on self-image, sexuality and urinary complaints were evidenced. The mean of additional concerns was lower in the age group from 50 to 59 years old, when compared to the mean values in the age groups from 31 to 49 years old (p=0.004) and from 60 to 75 years old (p=0.002). Conclusion: addressing issues related to sexuality and urinary complaints contribute to early identification of the symptoms caused by brachytherapy, as well as the implementation of measures, providing quality of life for the patient.

RESUMEN Objetivo: evaluar el efecto de la braquiterapia sobre la funcionalidad y la calidad de vida de mujeres con cáncer de cuello uterino. Método: estudio transversal y descriptivo realizado entre diciembre de 2019 y febrero de 2020 con 33 mujeres con neoplasia uterina en tratamiento de braquiterapia, monitoreadas en el Centro Oncológico do Nordeste - Brasil. Se aplicó el instrumento Funtional Assessment of Cancer Therapy - Cervix Cancer. Se compararon las medias de las subescalas y se analizó la correlación entre ellas por medio de las pruebas ANOVA y t de Student. Resultados: se evidenciaron requerimientos centrados en la autoimagen, la sexualidad y las quejas urinarias. La media de preocupaciones adicionales fue menor en los grupos etarios de 31 a 49 años (p=0.004) y de 60 a 75 (p=0.002). Conclusión: abordar cuestiones relacionadas con la sexualidad y las molestias urinarias contribuyen a la identificación precoz de los síntomas causados por la braquiterapia, así como a la implementación de medidas, proporcionando calidad de vida a la paciente.

Tamización primaria con prueba ADN-VPH en mujeres menores de 30 años: evaluación de tecnología sanitaria / Primary HPV-DNA screening in women under 30 years of age: health technology assessment

Antecedentes A partir del 2014 en Colombia se incorporó la Tamización primaria con prueba de Virus del Papiloma Humano (VPH) desde los 30 hasta los 65 años, cuando la prueba es positiva se hace triage con citología para remisión a colposcopia. Actualmente se discute la conveniencia de iniciar la tamización con prueba de ADN de VPH a partir de los 25 años. De esta manera, el objetivo de esta evaluación de tecnologías sanitarias es analizar la evidencia disponible en torno a la seguridad, efectividad, costoefectividad, valores y preferencias, dilemas éticos y aspectos relacionados con la implementación para el contexto colombiano de la prueba ADN-VPH como estrategia de tamización cervical en mujeres menores de 30 años. Dominios a evaluar Eficacia clínica y seguridad 1. Tasa acumulada de neoplasia intraepitelial cervical (NIC) grado 2 o más avanzado luego de 2 rondas de tamización. 2. Tasas acumuladas de cáncer invasor de cérvix luego de 2 rondas de tamización. 3. Seguridad: remisión a colposcopia. Costo-efectividad Costo efectividad para Colombia. Otros dominios considerados Aspectos éticos asociados a la tamización cervical en mujeres menores de 30 años. Aspectos organizacionales y del individuo. Barreras y facilitadores relacionados con la implementación en el contexto colombiano de la tamización cervical en mujeres menores de 30 años. Métodos Evaluación de efectividad y seguridad clínicas Se realizó una búsqueda sistemática de la literatura en MEDLINE, Embase y CENTRAL de revisiones sistemáticas y ensayos clínicos. Se calificó el cuerpo de la evidencia con la aproximación GRADE. Posteriormente, se convocó a un grupo interdisciplinario a una mesa de trabajo en donde se presentó la evidencia recuperada, dando paso a la discusión y a la construcción de las conclusiones, siguiendo los lineamientos de un consenso formal acorde a la metodología RAND/UCLA. Estudio económico Se hizo una búsqueda sistemática de la literatura de estudios que hubieran evaluado el costo-efectividad para Colombia. Resultados De 7.659 referencias recuperadas se incluyeron 8 estudios. Resultados clínicos Se realizó un análisis integrativo de 5 ensayos clínicos aleatorizados que cumplieron con los citerios de inclusión. Cuando se compara frente a la citología, la tamización primaria con ADN-VPH en mujeres menores de 30 años, podría asociarse con una mayor frecuencia de detección de lesiones NIC2+ durante la primera ronda de cribado (RR: 1.57; IC: 1,20 a 2,04; certeza en la evidencia baja), con una menor incidencia de NIC2+ (RR:0,67; IC: 0,48 a 0,92; certeza en la evidencia baja) y se asocia con una menor frecuencia de carcinoma invasor al término del seguimiento (RR: 0,19; IC: 0,07 a 0,53; certeza en la evidencia alta). Resultados económicos Desde el punto de vista económico, la alternativa de ADN-VPH y triage con citología desde los 25 años quizás representa la alternativa más costo-efectiva para Colombia (razón costo-efectividad incremental $8.820.980 COP año 2013). Otras implicaciones Dos estudios sugieren que las barreras de implementación, atribuibles a circunstancias de intermediación, de orden público y de carácter geográfico, podrían ser solventadas por nuevas tecnologías o estrategias de cribado. Es importante considerar alternativas de forma de administración y de prestación de servicios para solventar algunas barreras de aceptabilidad y acceso. Todo programa de tamización cervical debe contemplar los principios éticos de no maleficencia, beneficencia, autonomía y equidad. Futuros estudios deben enfocarse en analizar nuevas tecnologías de cribado con énfasis en población menor de 30 años. Conclusiones El uso de la prueba ADN-VPH como estrategia de tamización en mujeres menores de 30 años es una intervención probablemente efectiva y costoefectiva para Colombia. Futuros estudios deben enfocarse en analizar nuevas tecnologías de cribado con énfasis en población menor de 30 años.

Background Primary screening with Human Papilloma Virus (HPV) testing was introduced in Colombia in 2014 for individuals between 30 and 65 years of age. When the result is positive, cytology triage is performed for colposcopy referral. The convenience of initiating HPV-DNA testing for screening at 25 years of age is currently a subject of discussion. Therefore, the objective of this health technology assessment (HTA) is to analyze the available evidence regarding safety, efficacy, cost-effectiveness, values and preferences, ethical dilemmas and considerations pertaining to the implementation of the HPV-DNA test as a cervical screening strategy in women under 30 years of age in the Colombian context. Domains to be assessed Clinical efficacy and safety 1. Cumulative rate of cervical intraepithelial neoplasia (CIN) grade 2 or high-er after 2 screening rounds. 2. Cumulative rates of invasive cancer of the uterine cervix after 2 screening rounds. 3. Safety: referral to colposcopy Cost-effectiveness Cost-effectiveness for Colombia. Other domains considered Ethical considerations associated with cervical screening in women under 30 years of age. Organizational and individual considerations. Barriers and facilitators pertaining to the implementation of cervical screening in women under 30 years of age in the Colombian context. Methods Clinical efficacy and safety assessment A systematic literature search of systematic reviews and clinical trials was conducted in MEDLINE, Embase and CENTRAL. The body of evidence was rated using the GRADE approach. An interdisciplinary team was then convened to create a working group to review the retrieved evidence. This led to the discussion and construction of the conclusions following the guidelines of a formal consensus in accordance with the RAND/UCLA methodology. Economic study Systematic literature research of studies that had assessed cost-effectiveness for Colombia. Results Out of the 7,659 references retrieved, 8 studies were included. Clinical outcomes An integrative analysis of 5 randomized clinical trials that met the inclusion critera was performed. Compared with cytology, primary HPV-DNA testing in women under 30 years of age could be associated with a lower frequency of CIN+2 lesions during the first screening round (RR: 1.57; CI: 1.20 to 2.04; low evidence certainty), and a lower incidence of CIN+2 (RR: 0.67; CI: 0.48 to 0.92; low evidence certainty). Moreover, it is associated with a lower frequency of invasive carcinoma at the end of follow-up (RR: 0.19; CI: 0.07 to 0.53; high evidence certainty). Economic results From the financial point of view, the use of HPVDNA testing plus cytology-based triage starting at 25 years of age is perhaps the most cost-effective option for Colombia (incremental cost-effectiveness ratio, COP 8,820,980 in 2013). Other implications Two studies suggest that barriers to implementation attributable to intermediation, public unrest and geographic considerations could be overcome with the use of new screening technologies or strategies. It is important to consider administration and service provision alternatives in order to overcome some acceptability and access barriers. Any cervical screening program must take into consideration ethical principles of nonmaleficence, beneficence, autonomy and equity. Future studies should focus on analyzing new screening techniques with emphasis on the population under 30 years of age. Conclusions The use of HPV-DNA testing as a screening strategy in women under 30 years of age is a potentially efficacious and cost-effective intervention for Colombia. Future studies should focus on analyzing new screening technologies, with emphasis on the population under 30 years of age.

Prevalência de alterações de exame citopatológico e sua relação com lesões compatíveis com a infecção pelo Papiloma Vírus Humano e as neoplasias do colo uterino / Prevalence of changes on cytopathological exams and their relationship with injuries compatible with human papilloma virus infection and uterine cervical neoplasms

Introdução: O objetivo deste estudo é identificar a frequência de exames citológicos de colo uterino alterados e sua relação com a infecção pelo Papiloma Vírus Humano (HPV) e neoplasias. Métodos: Foram estudadas mulheres residentes em zona urbana, que fizeram exame citopatológico entre 2015 e 2017, com registros no Sistema de Informações do Câncer. Resultados: Foram realizados 25.323 exames citopatológicos, reunindo 815 alterações (3,2%). A faixa etária mais acometida foi entre 30-40 anos. A principal alteração encontrada foi "ASC-US" (431 casos ­ 52,8%). A Lesão Intraepitelial de Baixo Grau, que compreende o efeito citopático pelo HPV e neoplasia intraepitelial cervical Grau I, foi encontrada em 164 casos (20,1%). Após exame de colposcopia, 181 pacientes realizaram biópsia, sendo mais prevalente "NIC I com Alterações Compatíveis com Ação pelo HPV" (21,5%). Conclusão: Elevada prevalência de alterações que podem evoluir para neoplasias de colo uterino, com ênfase naquelas sugestivas da presença de HPV em pacientes abaixo de 25 anos.

Introduction: This study aimed to identify the frequency of changes on cervix cytopathological exams and its relationship with Human Papilloma Virus (HPV) infection and neoplasms. Methods: Women living in the urban area who underwent cytopathological examination from 2015 to 2017 were assessed, based on records from the Cancer Information System. Results: A total of 25,323 cytopathological exams were performed, reporting 815 changes (3.2%). The most affected age group was from 30 to 40 years. The most frequent change was "ASC-US" (431 cases ­ 52.8%). Low-grade intraepithelial lesion, which encompasses the cytopathic effect of HPV and cervical intraepithelial neoplasm grade I, was found in 164 cases (20.1%). After being examined by colposcopy, 181 patients underwent biopsy, whose most prevalent finding was "grade I CIN with Changes Compatible With HPV Action" (21.5%). Conclusion: There was a high prevalence of changes that can evolve to uterine cervical neoplasms, with emphasis on those suggestive of presence of HPV in patients younger than 25 years.

Clinical response and safety of apatinib monotherapy in recurrent, metastatic cervical cancer after failure of chemotherapy: a retrospective study / 부인종양

Intraepithelial cervical lesions in indigenous in Ecuador / Lesiones intraepiteliales cervicales en indígenas del Ecuador

The aim of this research was to determine the prevalence of cervical intraepithelial lesions in indigenous women of Ecuador 2017. A descriptive study was performed. Population was formed by 2489 indigenous women aged 15 to 64 years old, of which 396 users were chosen by spontaneous demand. Frequency values and percentages were taken from qualitative variables, while mean and standard deviation were taken from quantitative variables. Prevalence of intraepithelial lesions was 13,8%. Average age was 31 years old. Uncertain importance's squamous atypical cells were higher in 30-to-39-year-old group (46,7%). Non-specific atypical glandular cells were observed in 66,7% of 30-to-39-year-old group. Low-grade intraepithelial lesions were majorly found in 20-to-29-year-old group (43,8%). High-grade intraepithelial lesions were also seen in 20-to-29-year-old group. Conclusions were: prevalence of intraepithelial lesions in indigenous women of Ecuador was higher than 10% of reported in other studies, and more frequent in those aged 20 and 39 years old

El objetivo de esta investigación fue determinar la prevalencia de lesiones intraepiteliales cervicales en mujeres indígenas del Ecuador 2017. Se realizó un estudio descriptivo. La población estuvo compuesta por 2489 mujeres indígenas de 15 a 64 años, de las cuales 396 usuarias fueron elegidas por demanda espontánea. De las variables cualitativas se obtuvieron los valores de frecuencia y porcentajes, y de las cuantitativas la media y la desviación estándar. La prevalencia de las lesiones intraepiteliales fue del 13,8%. La edad promedio fue 31 años. Las células escamosas atípicas de importancia incierta fueron mayores en el grupo de edad de 30 a 39 años (46,7%). Se observaron células atípicas glandulares no específicas en el 66,7% en el grupo de 30 y 39 años de edad. Las lesiones intraepiteliales de bajo grado se presentaron más en el grupo de 20 y 29 años (43,8%). Las lesiones intraepiteliales de alto grado se identificaron también en el grupo de 20 a 29 años de edad. Las conclusiones fueron: la prevalencia de lesiones intraepiteliales en las mujeres indígenas del Ecuador fue superior al 10% de las reportadas en otros estudios, y más frecuente en aquellas de 20 y 39 años de edad

Distribution characteristics and risk factors of human papillomavirus infection in cervical intraepithelial neoplasia in Shanxi Province / 中国实用妇科与产科杂志

OBJECTIVE: To investigate the distribution characteristics and risk factors of HPV infection in the cervical intraepithelial neoplasia(CIN)cohort in Shanxi Province.METHODS: From June to December 2014,40,000 married women under the age of 65 years in Shanxi were screened for cervical cancer,and the abnormal cervical fluid-based cytology(TCT)was excluded.Gland microscopy and histopathological examination were performed.Finally a total of 2304 women were included in the study.Questionnaires were used to collect demographic characteristics and factors related to cervical cancer,and HPV typing was performed by flow-through hybridization.RESULTS: Among the 2304 subjects,the HPV infection age range was 36-40 years old;the top 5 HPV infection rates were HPV16/58/52/53/51.The top 5 HPV infectionrates in CIN2 及 以 上 were HPV16/58/31/33/52. HPV single infection accounted for 23.13%,multiple infection accounted for 9.51%,and with the increase of cervical lesion,degree HPV single infection rate and multiple infection rate also increased.Multivariate analysis showed that the risk of HPV infection in those who were educated for ≤ 9 years was 1.236 times(95% CI 1.029-1.484)of those who were educated for >9 years;the risk of HPV infection in the women with non-menstrual use of pads was 1.328 times(95% CI 1.016～1.736)of menopausal women,the risk of HPV infection in non-menopausalwomen was 2.407 times of those without(95% CI 2.012-2.880).CONCLUSION:s The high-risk age of HPV infection in Shanxi is 36-40 years old;the most common type of HPV infection is HPV16/58/52/53/51;the most pathogenic type is HPV16,58,31,33,52,whose distribution characteristics are different from those of other areas;short-term education,non-menopause,and non-menstrual use of pads are high-risk factors for HPV infection.

Analysis of depression and anxiety status and related factors in patients receving postoperative chemotherapy for cervical cancer / 中国实用妇科与产科杂志

OBJECTIVE: To investigate the status of depression and anxiety in postoperative chemotherapy patients with cervical cancer and to analyze related factors.METHODS: A retrospective analysis was made in 48 patients with cervical cancer who were treated from August 2015 to June 2018 in a Xuanwu Hospital,Capital Medical University were selected.All patients were treated with hysterectomy and postoperative chemotherapy and were investigated for depression and anxiety postoperatively,and clinical data and influencing factors were analyzed.RESULTS: All patients successfully completed surgery and chemotherapy,and there were no serious complications during or after surgery.The scores of depression and anxiety after chemotherapy were（46.40±5.30）points and（48.25±4.14）points,respectively in the 48 patients,the incidence of depression was 20.8%,and the incidence of anxiety was 22.9%.There were significant differences in the scores of depression and anxiety in the patients with different educational level,economic conditions,marital status,occupational status and morbidity（P<0.05）.The results of two-class Logistic regression analysis showed that the education level,economic conditions and marital status were the main independent risk factors for depression and anxiety in patients with postoperative chemotherapy for cervical cancer（P<0.05）.CONCLUSION: Depression and anxiety of postoperative chemotherapy patients with gynecologic cervical cancer are common,and the educational level,economic conditions and marital status are the main influencing factors.

Combined immunization with human papillomavirus type 18 fusion protein and recombinant vaccinia virus in mice / 中华实验和临床病毒学杂志

Objective@#To investigate the cellular and humoral immune responses induced by combined immunization with the fusion protein of human papillomavirus type 18 (HPV18) and the recombinant vaccinia virus.@*Methods@#Purified HPV18L231-600E7E6 fusion protein, expressed by prokaryotic expression system, were immunized in combination with the recombinant vaccinia virus vaccine expressing HPV18E7E6 fusion protein (rVV18E7E6) by using various prime-boost regiments in C57BL/6 mice. Cellular and humoral immune responses were analyzed by enzyme-linked immunospot assay (ELISPOT), enzyme-linked immunosorbent assay (ELISA), and pseudovirus neutralization assay.@*Results@#Higher levels of cellular immune responses were induced in mice primed with the HPV18L231-600E7E6 fusion protein/adjuvant CpG and boosted with the recombinant vaccinia virus rVV18E7E6, than in other immunized mice. Higher binding antibody level was induced, and low level neutralizing antibody against pseudovirus was detected simultaneously.@*Conclusions@#Priming with HPV18L231-600E7E6 fusion protein/CpG and boosting with the recombinant vaccinia virus rVV18E7E6 could induce higher cellular and humoral immune response in immunized mice, which might be taken as vaccine candidate for treatment of HPV18 chronic infection and postoperative adjuvant treatment for cervical cancer.

Factores asociados al uso de la citología cervicouterina en estudiantes de enfermería de la ciudad de cartagena

Introducción: El uso adecuado del tamizaje cérvico-uterino se configura como la mejor estrategia para la detección temprana del cáncer. Objetivo: Determinar los factores asociados al uso de la citología cérvico-uterina en estudiantes de enfermería de la ciudad de Cartagena. Métodos: Estudio analítico, con población de 1 109 estudiantes y tamaño de muestra de 469, seleccionadas por muestreo polietápico. Se utilizó un modelo de regresión para determinar las variables explicativas de la utilización adecuada de la citología. Resultados: Participaron 469 estudiantes, promedio de edad 20.8 años (DE=3,4). El 50.7% (238) ha realizado la prueba alguna vez, solo 31.3% (147) tienen uso adecuado. Ser mayor de 20 años (OR: 3,3 CI: 2,2 - 5,0), pertenecer a semestres superiores (OR: 1,9 CI: 1,3 - 2,9), tener pareja (OR: 3,1 CI: 1,9 - 5,0), tener hijos (OR: 2,9 CI: 1,8 - 4,7), haber estado embarazada (OR: 3,4 CI: 2,2 - 5,3), haber sufrido abortos (OR: 2,8 CI: 1,3 - 5,8) se asocian al uso adecuado. Conclusiones: Factores personales, principalmente antecedentes gineco-obstétricos, son predictores de la utilización adecuada de la citología.

Introduction: The appropriate use of Cervic-uterine screening test is configured as the best strategy for the early detection of cancer. Objetive: To determine the factors associated with the use of cervical-uterine cytology test in nursing students in the city of Cartagena. Methods: Analytical study, with a population of 1,109 subjects and sample size of 469, selected by multi-stage sampling. A regression model to determine the explanatory variables of the adequate use of cytology test was applied. Results: 469 students on average age of 20.8 years (SD = 3.4) participated. 50.7% (238) have done the test at some time, only 31.3% (147) is used adequately. Being older than 20 years (OR: 3.3 CI: 2.2 - 5.0), belong to higher semesters (OR: 1.9 CI: 1.3 -2.9), having a partner (OR: 3, 1 CI: 1.9 - 5.0), having children (OR: 2.9 CI: 1.8 - 4.7), having been pregnant (OR: 3.4 CI: 2.2 - 5.3), having practiced abortions (OR: 2.8 CI: 1.3 - 5.8) are associated with an adequate use. Conclusions: Personal factors, mainly gynecological-obstetric history, are predictors of an adequate use of cytology test.

Introdução: O uso adequado da triagem cervical configura-se como a melhor estratégia para a detecção precoce do câncer. Objetivo: Determinar os fatores associados ao uso da citologia cervical em estudantes de enfermagem na cidade de Cartagena. Métodos: Estudo analítico, com uma população de 1.109 alunos e tamanho de amostra de 469, selecionados por amostragem em múltiplos estágios. Um modelo de regressão foi utilizado para determinar as variáveis explicativas do uso adequado da citologia. Resultados: Participaram 469 estudantes, com idade média de 20,8 anos (DP = 3,4). 50,7% (238) fizeram o teste em algum momento, apenas 31,3% (147) tiveram uso adequado. Ser maior de 20 anos (OR: 3,3 IC: 2,2 - 5,0), pertencer a semestres superiores (OR: 1,9 IC: 1,3 - 2,9), ter companheiro (OR: 3, 1 IC: 1,9 - 5,0), ter filhos (OR: 2,9 IC: 1,8 - 4,7), ter estado gravida (OR: 3,4 IC: 2,2 - 5,3), ter sofrido abortamentos (OR: 2,8 IC: 1,3 -5,8) estão associados ao uso adequado. Conclusões: Fatores pessoais, principalmente antecedentes gineco-obstétricos, são preditores do uso adequado da citologia.

Programa de detección del cáncer cervicouterino: políticas públicas y experiencias de los actores que implementan el programa en el estado de Veracruz, México / Screening program for cervical cancer: public policies and experiences of actors who implement the program in the state of Veracruz, Mexico

RESUMEN El propósito fue analizar cómo se desarrolla el Programa de Detección del Cáncer Cervicouterino en una clínica de displasias y algunos centros de salud en el estado de Veracruz, a través de las representaciones y prácticas de los actores sociales que implementan el programa. Para ello, se realizaron entrevistas en profundidad y observación de la práctica de estos prestadores de servicios durante varios periodos a lo largo de 3 años entre 2009 y 2011. A partir de la información obtenida pretendemos dar cuenta de las dificultades, aciertos y resultados que dicho programa tiene como parte de una política pública, sobre la base de que las políticas en salud tienen como prioridad que toda la población se vea beneficiada por los servicios de atención preventiva y curativa, y si bien la evidencia nos muestra que las poblaciones marginadas no se ven beneficiadas por dichos programas, pareciera que esta información no permea los saberes populares y médicos.

ABSTRACT The aim of this article is to analyze the way in which the Screening Program for Cervical Cancer is carried out in a dysplasia clinic and related health centers in the state of Veracruz, through the representations and practices of the social actors who implement the program. In order to do so, in-depth interviews and observations of the practices of health service providers were carried out during different periods over the course of three years, from 2009 to 2011. Through the information obtained, the article explores the difficulties, achievements and results of this program as part of a public policy. Although a priority of public health policy is to see the whole population benefit from preventive and curative health care services, evidence shows that marginalized populations are not benefitted by such programs; such information does not however seem to permeate popular and medical knowledge.

Cytopathologic evaluation of patients submitted to radiotherapy for uterine cervix cancer / Avaliação citopatológica no seguimento de pacientes submetidas à radioterapia por câncer de colo uterino

Summary Cervical cancer is an important public health problem. Pap smear is the leading strategy of screening programs for cervical cancer worldwide. However, delayed diagnosis leads to more aggressive and less effective treatments. Patients with uterine cervix malignancies who are referred for radiotherapy have advanced-stage disease, which results in high rates of locoregional recurrence. The use of radiotherapy as a treatment for cervical cancer causes morphological changes in neoplastic and non-neoplastic epithelial cells, as well as in stromal cells, which make it difficult to diagnose the residual lesion, resulting in a dilemma in cytopathological routine. Based on the difficulties of cytopathologic evaluation for the follow-up of patients treated with radiotherapy for cervical cancer, our objective was to describe the actinic cytopathic effects. Our paper was based on a structured review including the period from June 2015 to April 2016, aiming at an exploratory-descriptive study. Bibliographic investigations were carried out through selection and analysis of articles, list of authors and keywords, selection of new articles focused on the analysis of bibliographic references to previously selected documents, as well as textbooks of recognized merit. The most incident actinic cytopathological alterations as described in the literature are: cellular gigantism, nuclear and cytoplasmic vacuolization, dyskeratosis, bi- and multinucleated (B/M) cells, macro and multiple nucleoli, anisokaryosis, anisonucleolosis and nuclear pyknosis. To date, a protocol has not been established that can precisely differentiate the morphological characteristics between benign cells with actinic effects from recurrent malignant cells on post-radiotherapy smears.

Resumo O câncer de colo uterino configura-se como um importante problema de saúde pública. O teste citopatológico é a principal estratégia de programas de rastreamento dessa neoplasia maligna em todo o mundo. Entretanto, a demora no diagnóstico ocasiona tratamentos mais agressivos e menos efetivos. Pacientes com neoplasia maligna de colo uterino que são encaminhadas para radioterapia apresentam doença em estádios avançados, e esse fato determina altos índices de recidiva locorregional. A utilização da radioterapia como tratamento do câncer do colo uterino provoca alterações morfológicas não só nas células epiteliais neoplásicas e não neoplásicas como também nas células estromais, o que dificulta o diagnóstico da lesão residual e resulta em um dilema na rotina citopatológica. Com base nas dificuldades da avaliação citopatológica do seguimento das pacientes pós-radioterapia, o objetivo deste trabalho foi descrever os efeitos citopáticos actínicos. O trabalho teve como base uma revisão estruturada no período de junho de 2015 a abril de 2016, visando a um estudo exploratório-descritivo. As investigações bibliográficas foram realizadas por meio de seleção e análise dos artigos, lista de autores e palavras-chave; seleção de novos artigos focada na análise de referências bibliográficas dos documentos previamente selecionados e livros-texto de relevância conceitual. As alterações citopatológicas actínicas mais incidentes descritas na literatura são: gigantismo celular, vacuolização nuclear e citoplasmática, disceratose, bi e multinucleações, macro e múltiplos nucléolos, anisocariose, anisonucleolose e picnose nuclear. Até o momento, não se conseguiu estabelecer um protocolo que possa diferenciar precisamente as características morfológicas entre células benignas com efeitos actínicos das células malignas recidivantes em esfregaços pós-radioterapia.

The utility of ADC in diagnosis of neuroendocrine carcinoma of the uterine cervix / 实用放射学杂志

Objective To assess the value of diffusion weighted imaging (DWI) and apparent diffusion coefficient (ADC) in differential diagnosis of neuroendocrine carcinoma of the uterine cervix (NECUC) from other tumors.Methods A total of 12 NECUCs,39 cervical squamous cell carcinomas (SCC) and 21 cervical adenocarcinomas (CA) confirmed by pathology were analyzed retrospectively.All the patients underwent conventional MRI and DWI.The ADC values were measured and compared among NECUC,SCC and CA.Diagnostic performance of ADC was compared using receiver operating characteristic curves (ROC).Results The mean ADC values of NECUC,SCC and CA were (0.66 ± 0.11) ×10-3 mm2/s,(0.86 ± 0.11) × 10-3 mm2/s and (1.04 ± 0.17) × 10-3 mm2 / s,with statistical differences between any two groups (P ＜0.001).The optimal cutoff values of ADC for differentiating NECUC and SCC was 0.681 ×10-3mm2/s with a sensitivity of 94.9％,specificity of 75.0％ and accuracy of 90.2％.The optimal cutoff values of ADC for differentiating NECUC and CA was 0.824× 10-3mm2/s with a sensitivity of 95.2％,specificity of 91.7％ and accuracy of 98.9％.Conclusion The differences of the mean ADC value are helpful for the differential diagnosis of NECUC,SCC and CA.

INADEQUATE PRACTICE RELATED OF THE PAPANICOLAOU TEST AMONG WOMEN / PRÁCTICA INADECUADA DE MUJERES SOBRE LA PRUEBA DE PAPANICOLAOU / PRÁTICA INADEQUADA DE MULHERES ACERCA DO PAPANICOLAOU

ABSTRACT Objective: to identify the factors related to inadequate practice of the Papanicolaou test among women in northeastern Brazil. Method: cross-sectional study using a KNOWLEDGE, ATTITUDE AND PRACTICE inquiry, performed from June to October, 2013, with 240 women aged between 24 and 59 years. Results: inadequacies were observed, particularly in knowledge, because, despite having information about the examination, it was only used to detect sexually transmitted infections. Regarding the issue of practice, it was noted that single women and those up to 29 years of age were more likely to present inadequate practice than the older and married women, increasing the likelihood of developing cervical cancer. The greater difficulty for performing the examination was the lack of materials (68.1%). Conclusion: clarification for women regarding the examination requires effective communication between the users and health professionals, as well as guarantees and support for the continuity of care by managers.

RESUMO Objetivo: identificar os fatores relacionados à prática inadequada do exame Papanicolaou em mulheres do interior do Nordeste brasileiro. Método: estudo transversal, no qual se utilizou o inquérito conhecimento, atitude e prática, no período de junho e outubro de 2013, com 240 mulheres entre 24 e 59 anos. Resultados: observaram-se inadequações, principalmente no conhecimento, pois, apesar de possuírem informações sobre o exame, utilizavam-no apenas para detectar doenças sexualmente transmissíveis. No quesito prática, percebeu-se que mulheres solteiras de até 29 anos apresentam maiores chances de prática inadequada do que aquelas com maior idade/casadas, aumentando a probabilidade de desenvolver câncer do colo do útero. A maior dificuldade para a realização do exame foi devido à falta de material (68,1%). Conclusão: o esclarecimento às mulheres acerca do exame necessita de comunicação efetiva entre usuárias e equipe de saúde, além da garantia e suporte à continuidade do cuidado dos gestores.

Intervenções que favorecem a adesão ao exame de colpocitologia oncótica: revisão integrativa / Intervenciones que favorecen la adhesión a la Prueba de Papanicolau: revisión integrativa / Interventions that facilitate adherence to Pap smear exam: integrative review

RESUMO Objetivo: identificar produções científicas que apresentem intervenções relevantes para implementar o Programa de Prevenção do Câncer Cérvico-Uterino, aumentando a adesão à realização do exame. Método: revisão integrativa da literatura, realizada por busca on-line, nas bases de dados: LILACS, SciELO e Pubmed®, abrangendo artigos publicados de 2009 a 2014. Resultados: trinta e oito artigos compuseram a amostra final do estudo. Estes indicaram as seguintes intervenções: utilização de gerente de caso, contato telefônico, carta-convite, atividades educativas, divulgação na mídia, agentes de saúde da comunidade, parcerias, rastreamento de base populacional e múltiplas intervenções. Conclusão: as pesquisas concentram-se entre mulheres provenientes de países em desenvolvimento, e estas intervenções são eficazes no aumento da adesão e do conhecimento destas mulheres em relação à prevenção do câncer cérvico-uterino.

RESUMEN Objetivo: identificar producciones científicas que manifiesten intervenciones importantes para la implementación del Programa de Prevención del Cáncer Cervical-Uterino, aumentando la adhesión a la realización de la prueba. Método: revisión integrativa de la literatura, realizada mediante búsqueda online en bases de datos LILACS, SciELO y PubMed®, incluyendo artículos publicados de 2009 a 2014. Resultados: muestra final compuesta por 38 artículos, que indicaron las siguientes intervenciones: utilización de gestor de caso, contacto telefónico, carta de invitación, actividades educativas, difusión en medios, agentes de salud comunitarios, alianzas, rastreo en base poblacional y múltiples acciones. Conclusión: las investigaciones se concentran en mujeres de países en desarrollo. Las intervenciones consiguen aumentar la adhesión y el conocimiento de estas mujeres respecto de la prevención del cáncer cervical-uterino.

ABSTRACT Objective: to identify scientific productions showing relevant interventions to implement the Cervical Uterine Cancer Prevention Program increasing adherence to exams. Method: integrative literature review through an online search in the following databases: LILACS, SciELO, and PubMed® comprising articles published from 2009 to 2014. Results: thirty-eight articles made up the study's final sample. Results showed the following interventions: use of case manager; telephone call; invitation letter; educational activities; media outreach work; community health agents; partnerships; population database screening; and multiple interventions. Conclusion: studies are mainly focused on women from developing countries and interventions are efficacious to increase women's knowledge about and adherence to prevention of cervical uterine cancer.

Influence of sub-field area on dose distribution in intensity-modulated radiotherapy for cervical cancer / 中华放射肿瘤学杂志

Objective To investigate the optimization of therapeutic regimen through the adjustment of the minimum sub-field area in intensity-modulated radiotherapy (IMRT) for cervical cancer,under the premise of no influence on the dose to target volume or organs at risk.Methods A total of 12 patients with pathologically confirmed cervical cancer were enrolled,and the prescribed dose to the planning target volume (PTV) was 50 Gy in 25 fractions.The Pinnacle 8.0m treatment planning system was used for all patients,and 16 IMRT plans were developed for each patient,with the application of 9 evenly distributed fixed incidence directions (0°,40°,80°,120°,160°,200°,240°,280°,and 320°),a minimum sub-field number of 80,and a minimum sub-field hop count (MU) of 5 MU.The range of sub-field area was 2-81 cm2.Direct machine parameter optimization was used for inverse-planned optimization calculation,and all the plans met the requirements of the clinical prescribed dose.The dose-volume histogram was used to evaluate the dose distribution in target volume and organs at risk.Results With the sub-field area increasing from 2 cm2 to 81cm2,the total hop count of IMRT plan was reduced from (1405±170) MU to (490±47) MU (P=0.000),and when the sub-field area increased above 6 cm×6 cm,the total hop count was reduced significantly (P=0.000).In the IMRT plan with a minimum sub-field area of 2-49 cm2,there was no significant difference in dose between the target volume and the organs at risk (P＞0.05).The dose to the rectum,the bladder,and both femoral heads showed no significant differences across the IMRT plans with different minimum sub-field areas (P＞0.05).Conclusions When the Pinnacle 8.0m treatment planning system is used to develop IMRT plans for cervical cancer,the requirements for clinical dose can still be met with a minimum sub-field area reaching 7 cm×7 cm,and there are significant reductions in sub-field hop count and total hop count.

Correlative factors of paclitaxel hypersensitivity in cervical cancer chemotherapy / 中国基层医药

Objective To investigate related factors of hypersensitivity reactions in patients undergoing paclitaxel chemotherapy for cervical cancer and provide measures for prevention of the side effects.Methods A ret-rospective survey was taken to analyze the clinical data from 186 cervical cancer patients who accepted paclitaxel chemotherapy from January 2013 to December 2014.SPSS 17.0 was used for single factor analysis and multi -factor logistic regression analysis.Results Among the 186 cervical cancer patients enrolled in this study,34 cases occurred hypersensitivity reactions.The incidence rate of anaphylaxis was 18.3%.Both eosinophil count of more than 0.2 × 109 /L(χ2 =4.171,P <0.05)and history of drug allergy(χ2 =10.667,P <0.01)were not merely risk factors of anaphylaxis,but also independent risk factors(OR =4.691,2.257,all P <0.01 ).Conclusion The incidence of hypersensitivity after paclitaxel chemotherapy in cervical cancer patients is high.Eosinophil count ≥ 0.2 ×109 /L before chemotherapy and history of drug allergy are not merely risk factors of anaphylaxis,but also independent risk factors,which require more attention.

Desigualdades socioeconômicas e regionais na cobertura de exames citopatológicos do colo do útero / Desigualdades socioeconómicas y regionales en la cobertura de exámenes citopatológicos del cuello uterino / Socioeconomic and regional inequalities of pap smear coverage

RESUMO Objetivos Identificar desigualdades socioeconômicas e regionais na cobertura de exames citopatológicos do colo do útero no Rio Grande do Sul. Métodos Estudo ecológico utilizou dados dos sistemas de informação em saúde de 2011-2012 para estimar coberturas anuais de exames para todas as mulheres residentes e para as não beneficiárias de planos privados de saúde. Desigualdades na cobertura foram estimadas conforme o Índice de Vulnerabilidade Social Municipal, macrorregiões e regiões de saúde. Resultados A prevalência de mulheres não beneficiarias de planos privados de saúde variou de 38,1% a 94,2% entre regiões de saúde. A cobertura estadual foi 17,3% para todas as residentes e 23,8% para as não beneficiárias de planos privados. As maiores coberturas ocorreram nos municípios em maior vulnerabilidade social e nas regiões com maior prevalência de planos privados. Conclusões A prevalência de planos privados de saúde deve ser considerada em estudos da cobertura de serviços pelo Sistema Único de Saúde.

RESUMEN Objetivos Identificar desigualdades socioeconómicas y regionales en la cobertura de exámenes citopatológicos del cuello uterino en Rio Grande do Sul. Métodos Estudio ecológico utilizó datos de los sistemas de información en salud de 2011-2012 para estimar coberturas anuales de exámenes para la totalidad de mujeres residentes y para no beneficiarias de planes privados de salud. Se estimaron las desigualdades según el Índice de Vulnerabilidad Social Municipal, las macroregiones y las regiones de salud. Resultados La prevalencia de mujeres no beneficiarias de planes privados de salud tuvo una variación de 38.1% a 94.2% entre las regiones de salud. La cobertura del estado fue de 17.3% para la totalidad de residentes y el 23.8% para no beneficiarias de planes privados. Las mayores coberturas sucedieron en los municipios de mayor vulnerabilidad social y regiones con mayor prevalencia de planes privados. Conclusiones La prevalencia de los planes privados de salud debe ser considerada en los estudios de cobertura de servicios del Sistema Único de Salud (SUS).

ABSTRACT Objectives To identify socioeconomic and regional inequalities of pap smear coverage in the state of Rio Grande do Sul. Methods An ecological study based on data of the 2011-2012 national health information system to estimate the annual coverage of pap smears for the overall female population of the state and for women without private health insurance. We estimated annual pap smear coverage according to the Municipal Social Vulnerability Index and health macro-regions and regions of the state. Results The percentage of women without private health insurance ranged from 38.1% to 94.2% in the health regions. Pap smear coverage was 17.3% for the overall female population and 23.8% for women without private health insurance. Pap smear coverage was higher in more socially vulnerable municipalities and regions with a higher percentage of women with private health insurance. Conclusions The prevalence of private health insurance should be considered in studies that address the coverage of the Brazilian Unified Health System (SUS).

Validation of the Adherence Determinants Questionnaire scale among women with breast and cervical cancer / Validação da escala Adherence Determinants Questionnaire entre mulheres com câncer de mama e cervical / Validación de la escala Adherence Determinants Questionnaire entre mujeres con cáncer de mama y cervical

Objectives: the aim was to translate and culturally adapt the Adherence Determinants Questionnaire scale for the Portuguese language in the Brazilian context, and to check its reliability and validity to analyze the elements of the adherence of patients to the clinical treatment for breast and cervical cancer.Method: this was a methodological study, carried out in two oncology reference centers. The sample consisted of 198 participants, with 152 being treated for breast cancer and 46 being treated for cervical cancer. The content validation was performed by a committee of experts. The construct validation was demonstrated through factor analysis and the reliability was analyzed using Cronbach's alpha.Results: the committee of experts made the necessary adjustments so that the scale was adapted to the Brazilian context. The factor analysis suggested a reduction from seven to five factors and the maintenance of 38 items similar to those of the original scale. The reliability, investigated through Cronbach's alpha, was .829, showing high internal consistency.Conclusion: it was concluded that the Brazilian version of the Adherence Determinants Questionnaire scale is a valid and reliable instrument that is able to measure the elements of adherence to the treatment for breast and cervical cancer.

Objetivos: objetivou-se traduzir e adaptar culturalmente a escala Adherence Determinants Questionnaire para a língua Portuguesa, no contexto brasileiro, e verificar a confiabilidade e a validade da mesma para analisar os elementos da adesão das pacientes ao tratamento clínico do câncer de mama e cervical.Método: trata-se de estudo metodológico, realizado em dois centros de referência em oncologia. A amostra foi composta por 198 participantes, sendo 152 em tratamento para câncer de mama e 46 em tratamento para câncer cervical. A validação de conteúdo foi realizada por um comitê de especialistas. Já a validação de construto se deu pela análise fatorial e a confiabilidade foi analisada por meio do alfa de Cronbach.Resultado: o comitê de especialistas fez os ajustes necessários para que a escala fosse adaptada ao contexto brasileiro. A análise fatorial sugeriu a redução de sete para cinco fatores, bem como a permanência dos 38 itens semelhantes à escala original. A confiabilidade averiguada pelo alfa de Cronbach foi de 0,829, revelando alta consistência interna.Conclusão: conclui-se que a escala Adherence Determinants Questionnaire - Versão Brasileira - é um instrumento válido, confiável e capaz de mensurar os elementos de adesão ao tratamento do câncer de mama e cervical.

Objetivos: se objetivó traducir y adaptar culturalmente la escala Adherence Determinants Questionnaire para la lengua Portuguesa, en el contexto brasileño, y verificar la confiabilidad y la validez de la misma para analizar los elementos de la adhesión de las pacientes al tratamiento clínico del cáncer de mama y cervical.Método: se trata de estudio metodológico, realizado en dos centros de referencia en oncología. La muestra fue compuesta por 198 participantes, siendo 152 en tratamiento para cáncer de mama y 46 en tratamiento para cáncer cervical. La validación de contenido fue realizada por un comité de especialistas. La validación de constructo se realizó por análisis factorial y la confiabilidad fue analizada por medio del Alfa de Cronbach.Resultado: el comité de especialistas hizo los ajustes necesarios para que la escala fuese adaptada al contexto brasileño. El análisis factorial sugirió la reducción de siete para cinco factores, así como la permanencia de los 38 ítems semejantes a la escala original. La confiabilidad averiguada por el Alfa de Cronbach fue de 0,829, revelando alta consistencia interna.Conclusión: se concluye que la escala Adherence Determinants Questionnaire - Versión Brasileña - es un instrumento válido, confiable y capaz de medir los elementos de adhesión al tratamiento del cáncer de mama y cervical.

Conización cervical más linfadenectomía pélvica radical bilateral comomanejo conservador del cáncer de cérvix IB 1: reporte de un caso y revisión de la literatura / Cervical conisation plus radical bilateral pelvic lymph node dissection as conservative treatment for cervical cancer IB1: case report and review of the literature

Objetivo: describir el caso de una paciente con cáncer de cérvix en estadio FIGO IB1, a quien se le realizó conización cervical más linfadenectomía pélvica para preservar su fertilidad, y hacer una revisión de la literatura sobre sus indicaciones, efectividad y seguridad en términos de resultados oncológicos y obstétricos.Materiales y métodos: se presenta el caso de una paciente de 26 años, con diagnóstico de adenocarcinoma infiltrante de cérvix estadio IB1, atendida en la Clínica Julio Enrique Medrano de SaludCoop, Barranquilla (Colombia), institución de alto nivel de complejidad que atiende pacientes pertenecientes al régimen contributivo del sistema de seguridad social. Se realizó conización cervical más linfadenectomía pélvica, para preservar fertilidad. Al segundo año de seguimiento logró embarazo a término y 48 meses después se encuentra libre de enfermedad. Se realizó una búsqueda electrónica, sin restricción de idioma, de la literatura publicada hasta julio de 2015 con las palabras claves: Uterine Cervical Neoplasms, Fertility Preservation, Conization, Gynecologic Surgical Procedures y Lymph Node Excision, en las bases de datos Medline, Embase, CINAHL y Cochrane, y en las referencias bibliográficas de estudios recuperados.Resultados: se identificaron nueve artículos: ocho estudios de cohorte y un de reporte de caso. La conización cervical más linfadenectomía pélvica radical bilateral, es un procedimiento menos radical, seguro y efectivo para el manejo conservador del cáncer de cérvix de bajo riesgo. En pacientes sometidas a conización se reportan recidivas en un 2,84 %; 38 % logran embarazo, de los cuales el 70,2 % llegan a término.Conclusiones: la conización cervical más linfadenectomía pélvica radical bilateral podría ser una opción para el manejo de pacientes con cáncer de cérvix en estadios iniciales considerados de bajo riesgo que deseen conservar su fertilidad

Objective: To describe the case of a patient with cervical cancer FIGO stage IB1 taken to conisation and pelvic lymphadenectomy with the aim of preserving fertility, and to conduct a search in the literature regarding indications, effectiveness and safety of this procedure in terms of obstetric and oncologic outcomes.Materials and methods: We present the case of a 26-year old female patient seen at the Julio Enrique Medrano SaludCoop Clinic (Barranquilla, Colombia), a high-complexity institution that serves a population belonging to the contributory regime of the social security system. The patient was diagnosed with infiltrating cervical carcinoma stage IB1. She was taken to cervical cone biopsy plus pelvic lymph node dissection in order to preserve fertility. Two years into follow-up she achieved a term pregnancy, and 48 months later she is disease-free. An online search was conducted of the literature published until July 2015, with no language restriction, using the key words Uterine Cer vical Neoplasms, Fertilit y Preser vation, Conization, Gynaecologic Surgical Procedures and Lymph Node Excision in the Medline, Embase, CINAHL and Cochrane databases and in the bibliographic references of retrieved studies.Results: Overall, 9 articles were identified: 8 cohort studies and 1 case report. Cervical conisation plus bilateral radical pelvic lymphadenectomy is a less radical, safer and effective procedure for the conservative management of low-risk cervical cancer. A relapse rate of 2.84 % has been reported in patients subjected to conisation, pregnancy is achieved in 38 % of cases and, of those, 70.2 % come to term.Conclusions: Cervical conisation plus bilateral radical pelvic lymphadenectomy may be a management option for patients with low-risk, early-stage cervical cancer who wish to preserve their fertility